Provided by Tiger Fintech (Singapore) Pte. Ltd.

RENOVARO BIOSCIENCES INC

0.3359
+0.02648.53%
Post-market: 0.33590.00000.00%19:12 EDT
Volume:632.22K
Turnover:211.16K
Market Cap:53.77M
PE:-0.41
High:0.3489
Open:0.3300
Low:0.3202
Close:0.3095
Loading ...
Oct 02, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 30, 2023

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Sep 30, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Aug 07, 2023

Major Issues Report

Form 8-K - Current report
Jul 28, 2023

Major Issues Report

Form 8-K - Current report
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 28, 2023

Major Issues Report

Form 8-K - Current report
Jun 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 23, 2023

Major Issues Report

Form 8-K - Current report
Jun 08, 2023

Major Issues Report

Form 8-K - Current report
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 19, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]